Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2005 | 10-2004 | 10-2003 | 10-2002 | 10-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12 | 85 | 36 | 61 | 0 |
| Receivables | 199 | 99 | 88 | 142 | 71 |
| Inventories | 314 | 254 | 256 | 328 | 339 |
| TOTAL | $556 | $461 | $409 | $550 | $438 |
| Non-Current Assets | |||||
| PPE Net | 126 | 161 | 191 | 180 | 232 |
| Intangibles | N/A | N/A | N/A | N/A | 101 |
| TOTAL | $126 | $161 | $191 | $180 | $334 |
| Total Assets | $682 | $623 | $600 | $730 | $771 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 45 | 45 | 45 | 158 |
| Accounts payable and accrued liabilities | 195 | 183 | 147 | 207 | 135 |
| Other current liabilities | 191 | 171 | 136 | 162 | 1 |
| TOTAL | $386 | $399 | $328 | $415 | $294 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $386 | $399 | $328 | $415 | $294 |
| Shareholders' Equity | |||||
| Retained earnings | -2,285 | -2,356 | -2,308 | -2,265 | -2,003 |
| TOTAL | $296 | $224 | $272 | $315 | $477 |
| Total Liabilities And Equity | $682 | $623 | $600 | $730 | $771 |